Click a link below to view the mailing archive as if it had been sent to you.
| 2010-12-31 12:00 | | New Drug Approvals Fall in 2010 as Safety Concerns Slow U.S. FDA Decisions and more... |
| 2010-12-31 00:00 | | What's Next for Achillion Pharma? and more... |
| 2010-12-30 12:00 | | Seattle Genetics Looks Attractive on Fundamentals, Pipeline and more... |
| 2010-12-30 00:00 | | Pfizer buys Synbiotics for undisclosed amount and more... |
| 2010-12-29 12:00 | | DARA Biosciences Looks to Raise $4M and more... |
| 2010-12-29 00:00 | | Party not over for Repros shares and more... |
| 2010-12-28 12:00 | | Sucampo Pharmaceuticals - Upgrades & Downgrades and more... |
| 2010-12-27 12:00 | | Frank Baldino Jr., Founder of Pharmaceutical Company, Dies at 57 and more... |
| 2010-12-23 12:00 | | Confidential Witness: J&J Knew Tylenol Factory Was Failing in 2007 and more... |
| 2010-12-23 00:00 | | AstraZeneca, Abbott end Certriad license deal and more... |
| 2010-12-22 12:00 | | 2011 Big-Cap Biotech Preview and more... |
| 2010-12-22 00:00 | | Teva will market generic Actos starting in 2012 and more... |
| 2010-12-21 12:00 | | When is a High Sense of Urgency a Liability for Pharmaceutical Companies? and more... |
| 2010-12-21 00:00 | | Should You Get Out of Medicis Pharmaceutical Before Next Quarter? and more... |
| 2010-12-20 12:00 | | The Winner of ASH 2010: Seattle Genetics and more... |
| 2010-12-20 00:00 | | Health Care Stocks: Winners vs. Losers (video) and more... |
| 2010-12-19 12:00 | | The codeine regulations: a bitter pill to swallow? (in Ireland) and more... |
| 2010-12-19 00:00 | | Stason Pharma gets world-wide non-exclusive license to use Lonza's GS Gene Expression System and more... |
| 2010-12-18 00:00 | | Cephalon Mourns the Passing of Founder, Chairman and CEO, Frank Baldino Jr., Ph.D. |
| 2010-12-17 12:00 | | GSK signs deal to sell ParkinsonâÔö£é?öé??Ôö£é?ö?ñós drug and more... |
| 2010-12-17 00:00 | | AstraZeneca Fails to Win U.S. FDA Approval for Plavix Competitor Brilinta and more... |
| 2010-12-16 12:00 | | J&J names vice-chairmen and more... |
| 2010-12-15 12:00 | | Cypress jumps on buyout deal and more... |
| 2010-12-15 00:00 | | 3 Ways to Play Biotech With Options and more... |
| 2010-12-14 12:00 | | Charles River Laboratories expects 2011 profit growth, raises 2010 guidance and more... |
| 2010-12-14 00:00 | | Buyback, dividend could lift Pfizer stock-Barron's and more... |
| 2010-12-13 12:00 | | Amgen, Actelion Talk but No Offer Made and more... |
| 2010-12-12 00:00 | | Avanir Pharmaceuticals Chart Point to Possible Trend Reversal and more... |
| 2010-12-11 12:00 | | Pacific Biosciences Shares Popped: What You Need to Know and more... |
| 2010-12-11 00:00 | | Cypress Surges After Ramius Boosts Buyout Offer 29 Percent to $212 Million and more... |
| 2010-12-10 12:00 | | Molecular Insight Files for Chapter 11 and more... |
| 2010-12-10 00:00 | | Bayer, Boehringer, Novartis vie for vet ops-sources and more... |
| 2010-12-09 12:00 | | Orexigen Approval Shows That Diversification Strategy Can Work and more... |
| 2010-12-09 00:00 | | Winners and Losers at the Hematology Society Meeting and more... |
| 2010-12-08 12:00 | | Clearing Up the Uncertainty Around MannKindâÔö£é?öé??Ôö£é?ö?ñós Afrezza and more... |
| 2010-12-08 00:00 | | Drug Pipeline Pulse Check: Spectrum, QRxPharma, CytRx and Impax and more... |
| 2010-12-07 12:00 | | Sanofi Said Unwilling to Meet Both Genzyme Demands and more... |
| 2010-12-07 00:00 | | Why the Street Should Love King Pharmaceuticals' Earnings and more... |
| 2010-12-06 12:00 | | Pfizer Change of Guard Won't Make a Difference and more... |
| 2010-12-06 00:00 | | Pfizer CEO Kindler Steps Down Unexpectedly and more... |
| 2010-12-05 12:00 | | U.S. Pharma: Latest Analyst Actions |
| 2010-12-05 00:00 | | Sun Pharma to delist troubled US subsidiary and more... |
| 2010-12-03 12:00 | | Pfizer Properly Warned About Prempro Health Risks, Jury Finds and more... |
| 2010-12-03 00:00 | | AstraZeneca: FDA panel says vandetanib could help some medullary thyroid cancer patients and more... |
| 2010-12-02 12:00 | | Regulatory experts see huge challenges on biosimilar rules and more... |
| 2010-12-02 00:00 | | Glaxo Fails to Win PanelâÔö£é?öé??Ôö£é?ö?ñós Vote for Wider Avodart Use and more... |
| 2010-12-01 12:00 | | Axcan buying Eurand for $583 million and more... |
